Femme Homme
- | Pays :
- France
- | Organes : -
- | Spécialités : -
Extrait
This is a global pregnancy registry to evaluate the outcomes of pregnancy in women with multiple sclerosis who have been exposed to prolonged-release fampridine since the first day of their last menstrual period prior to conception or at any time during pregnancy.
Critère d'inclusion
- Multiple sclerosis ,pregnancy